NOV 01, 2022 10:00 AM PDT

Flow cytometric gene mutation assay, made possible by immunomagnetic separation, achieves OECD regulatory status

Sponsored by: Miltenyi Biotec
Speakers

Abstract
Date:  November 01, 2022
Time: 10:00am (PDT),  1:00pm (EDT), 6:00pm (CET)
 
Litron laboratories developed the Pig-a gene mutation assay as a means to simply and reliably evaluate the potential mutagenicity of compounds. Commercially available from Litron Laboratories under the name MutaFlow, this method utilizes the endogenous phosphatidylinositol glycan class A gene found in most mammalian species as a reporter of gene mutation. During early development, the assay was challenged by the rare event nature of this analysis and the time and effort required to interrogate a sufficient number of events in order to reliably calculate a mutation frequency in peripheral red blood cells. Following the addition of labeling of cells with superparamagnetic beads and the use of immunomagnetic columns to focus analysis on the cells of interest, the sample throughput and number of events scored was dramatically increased.
 
This critical improvement facilitated the continued development and commercialization of the assay into a successful line of kits and services. Subsequent to additional work by Litron and others, the validation of the assay was deemed sufficient to submit for regulatory approval in the form of Test Guideline development by the Organization of Economic Cooperation and Development (OECD). The formal “Test Guideline 470 Mammalian Erythrocyte Pig-a Gene Mutation Assay” was adopted in June of this year and serves to establish the assay as applicable for regulatory safety submissions.
 
Learning Objectives
  • The MutaFlow Assay is an endogenous gene mutation assay that can be readily integrated with existing animal studies performed for product safety assessment
  • The ability to focus analysis on the rare mutation phenotype is made possible by the combination of immunomagnetic separation and flow cytometry
  • The Pig-a assay is now supported by an OECD Test Guideline (TG470) to facilitate use under GLP in support of regulatory submissions
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
OCT 11, 2022 8:00 AM PDT
C.E. CREDITS
OCT 11, 2022 8:00 AM PDT
Date: October 11, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding o...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
NOV 09, 2022 8:00 AM PST
C.E. CREDITS
NOV 09, 2022 8:00 AM PST
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
Loading Comments...
Show Resources